Sector: Consumer Non-Cyclicals | Industry: Food Processing |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 1410 Lakeside Parkway, Suite 200 FLOWER MOUND TX 75028 |
Tel: | N/A |
Website: | https://us.mannatech.com |
IR: | See website |
Key People | ||
J. Stanley Fredrick Chairman of the Board | Landen Fredrick President, Chief Executive Officer, Chief Financial Officer | Christopher J. Simons Regional President EMEAA, Central and South America |
Ronald D. Norman Senior Vice President, Treasurer | Erin K. Barta General Counsel and Corporate Secretary |
Business Overview |
Mannatech, Incorporated is a global wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, Essentials, and Home Living. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies. Home Living includes Organt and PURO. |
Financial Overview |
For the fiscal year ended 31 December 2023, Mannatech Inc revenues decreased 4% to $132M. Net loss decreased 50% to $2.2M. Revenues reflect Consolidated Product Sales segment decrease of 4% to $125.3M, Consolidated Pack Sales segment decrease of 10% to $5.6M, Asia Pacific segment decrease of 5% to $79.4M, EMEA segment decrease of 17% to $9.8M. |
Employees: | 213 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $9.19M as of Dec 31, 2023 |
Annual revenue (TTM): | $131.96M as of Dec 31, 2023 |
EBITDA (TTM): | $0.66M as of Dec 31, 2023 |
Net annual income (TTM): | -$2.24M as of Dec 31, 2023 |
Free cash flow (TTM): | -$3.87M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 1,884,814 as of Feb 29, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |